TY - JOUR
T1 - Sleep
T2 - Important considerations for the prevention of cardiovascular disease
AU - Grandner, Michael A.
AU - Alfonso-Miller, Pamela
AU - Fernandez-Mendoza, Julio
AU - Shetty, Safal
AU - Shenoy, Sundeep
AU - Combs, Daniel
N1 - Funding Information:
Dr Grandner is supported by K23HL110216. Dr Grandner has received consulting fees from FitBit, Bayer, Nexalin, and the National Sleep Foundation, and grant support from Kemin Industries.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Purpose of review Sleep plays many roles in maintenance of cardiovascular health. This review summarizes the literature across several areas of sleep and sleep disorders in relation to cardiometabolic disease risk factors. Recent findings Insufficient sleep duration is prevalent in the population and is associated with weight gain and obesity, inflammation, cardiovascular disease, diabetes, and mortality. Insomnia is also highly present and represents an important risk factor for cardiovascular disease, especially when accompanied by short sleep duration. Sleep apnea is a well-characterized risk factor for cardiometabolic disease and cardiovascular mortality. Other issues are relevant as well. For example, sleep disorders in pediatric populations may convey cardiovascular risks. Also, sleep may play an important role in cardiovascular health disparities. Summary Sleep and sleep disorders are implicated in cardiometabolic disease risk. This review addresses these and other issues, concluding with recommendations for research and clinical practice.
AB - Purpose of review Sleep plays many roles in maintenance of cardiovascular health. This review summarizes the literature across several areas of sleep and sleep disorders in relation to cardiometabolic disease risk factors. Recent findings Insufficient sleep duration is prevalent in the population and is associated with weight gain and obesity, inflammation, cardiovascular disease, diabetes, and mortality. Insomnia is also highly present and represents an important risk factor for cardiovascular disease, especially when accompanied by short sleep duration. Sleep apnea is a well-characterized risk factor for cardiometabolic disease and cardiovascular mortality. Other issues are relevant as well. For example, sleep disorders in pediatric populations may convey cardiovascular risks. Also, sleep may play an important role in cardiovascular health disparities. Summary Sleep and sleep disorders are implicated in cardiometabolic disease risk. This review addresses these and other issues, concluding with recommendations for research and clinical practice.
KW - cardiovascular
KW - diabetes
KW - insomnia
KW - sleep
KW - sleep apnea
UR - http://www.scopus.com/inward/record.url?scp=84979998442&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000324
DO - 10.1097/HCO.0000000000000324
M3 - Review article
C2 - 27467177
AN - SCOPUS:84979998442
SN - 0268-4705
VL - 31
SP - 551
EP - 565
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 5
ER -
